• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Application of the Gross Motor Function Measure in children with conditions other than cerebral palsy: A systematic review.粗大运动功能测量在非脑瘫儿童中的应用:一项系统评价。
Dev Med Child Neurol. 2025 Nov;67(11):1421-1442. doi: 10.1111/dmcn.16465. Epub 2025 Aug 14.
2
Vesicoureteral Reflux膀胱输尿管反流
3
Bisphosphonate use in children with cerebral palsy.双膦酸盐在脑瘫儿童中的应用。
Cochrane Database Syst Rev. 2021 Jul 5;7(7):CD012756. doi: 10.1002/14651858.CD012756.pub2.
4
Intrathecal baclofen for treating spasticity in children with cerebral palsy.鞘内注射巴氯芬治疗小儿脑性瘫痪痉挛状态
Cochrane Database Syst Rev. 2015 Nov 13;2015(11):CD004552. doi: 10.1002/14651858.CD004552.pub2.
5
Treadmill interventions with partial body weight support in children under six years of age at risk of neuromotor delay.对有神经运动发育迟缓风险的六岁以下儿童进行的带有部分体重支持的跑步机干预。
Cochrane Database Syst Rev. 2011 Dec 7(12):CD009242. doi: 10.1002/14651858.CD009242.pub2.
6
Treadmill interventions in children under six years of age at risk of neuromotor delay.针对有神经运动发育迟缓风险的六岁以下儿童的跑步机干预措施。
Cochrane Database Syst Rev. 2017 Jul 29;7(7):CD009242. doi: 10.1002/14651858.CD009242.pub3.
7
Exercise interventions for cerebral palsy.脑瘫的运动干预
Cochrane Database Syst Rev. 2017 Jun 11;6(6):CD011660. doi: 10.1002/14651858.CD011660.pub2.
8
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
9
Gross Motor Function Measure-66 Item Sets for use with infants and toddlers at high risk for cerebral palsy: Construct validity and responsiveness.用于脑瘫高危婴幼儿的粗大运动功能测量-66项套装:结构效度与反应性
Dev Med Child Neurol. 2025 Aug;67(8):1063-1074. doi: 10.1111/dmcn.16259. Epub 2025 Feb 14.
10
Pharmacological interventions for pain in children and adolescents with life-limiting conditions.针对患有危及生命疾病的儿童和青少年疼痛的药物干预措施。
Cochrane Database Syst Rev. 2015 Mar 13;2015(3):CD010750. doi: 10.1002/14651858.CD010750.pub2.

本文引用的文献

1
Proposed updated description of cerebral palsy.脑性瘫痪的拟议更新描述。
Dev Med Child Neurol. 2025 Jun;67(6):700-709. doi: 10.1111/dmcn.16274. Epub 2025 Apr 11.
2
Principles for good scholarship in systematic reviews.系统评价中的良好学术规范原则。
Dev Med Child Neurol. 2024 Apr;66(4):415-421. doi: 10.1111/dmcn.15719. Epub 2023 Aug 1.
3
Motor and cognitive response to intensive multidisciplinary therapy: the first reported case of congenital Zika virus syndrome.对强化多学科治疗的运动和认知反应:首例先天性寨卡病毒综合征报告病例
Physiother Theory Pract. 2024 Jun;40(6):1362-1371. doi: 10.1080/09593985.2023.2165887. Epub 2023 Jan 10.
4
Treatment of Mitochondrial Phenylalanyl-tRNa-Synthetase Deficiency (FARS2) with Oral Phenylalanine.口服苯丙氨酸治疗线粒体苯丙氨酸-tRNA 合成酶缺乏症(FARS2)。
Neuropediatrics. 2023 Oct;54(5):351-355. doi: 10.1055/a-2008-4230. Epub 2023 Jan 5.
5
Motor Responses in Pediatric Pompe Disease in the ADVANCE Participant Cohort.小儿庞贝病 ADVANCE 参与者队列的运动反应。
J Neuromuscul Dis. 2022;9(6):713-730. doi: 10.3233/JND-210784.
6
Efficacy of microsurgery for congenital neural tube defects in newborns.新生儿先天性神经管缺陷显微手术的疗效
Am J Transl Res. 2022 Aug 15;14(8):5574-5582. eCollection 2022.
7
Effect of neurodevelopmental treatment in children with congenital Zika syndrome: A pilot study.先天性寨卡综合征患儿的神经发育治疗效果:一项初步研究。
J Paediatr Child Health. 2022 Nov;58(11):2008-2015. doi: 10.1111/jpc.16139. Epub 2022 Jul 30.
8
Psychometric outcome measures in beta-propeller protein-associated neurodegeneration (BPAN).β-螺旋桨蛋白相关神经退行性疾病(BPAN)的心理测量学结果测量。
Mol Genet Metab. 2022 Sep-Oct;137(1-2):26-32. doi: 10.1016/j.ymgme.2022.07.009. Epub 2022 Jul 20.
9
The Effect of Early-Life Seizures on Cognitive and Motor Development: A Case Series.早期癫痫发作对认知和运动发育的影响:病例系列研究。
Pediatr Phys Ther. 2022 Jul 1;34(3):425-431. doi: 10.1097/PEP.0000000000000918. Epub 2022 Jun 8.
10
Effects of Robotic Interactive Gait Training Combined with Virtual Reality and Augmented Reality on Balance, Gross Motor Function, Gait Kinetic, and Kinematic Characteristics in Angelman Syndrome: A Case Report.机器人交互式步态训练结合虚拟现实和增强现实对天使综合征患者平衡、粗大运动功能、步态动力学和运动学特征的影响:一例报告
Children (Basel). 2022 Apr 12;9(4):544. doi: 10.3390/children9040544.

粗大运动功能测量在非脑瘫儿童中的应用:一项系统评价。

Application of the Gross Motor Function Measure in children with conditions other than cerebral palsy: A systematic review.

作者信息

Abe Hirokazu, Higashi Shuhei, Himuro Nobuaki

机构信息

Department of Health Care and Child Development, Saitama Children's Medical Center, Saitama, Japan.

Department of Physical Therapy, Kitakyushu Children's Rehabilitation Center, Kitakyushu, Japan.

出版信息

Dev Med Child Neurol. 2025 Nov;67(11):1421-1442. doi: 10.1111/dmcn.16465. Epub 2025 Aug 14.

DOI:10.1111/dmcn.16465
PMID:40813751
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12521613/
Abstract

AIM

To investigate the application and evaluate the measurement properties of the Gross Motor Function Measure (GMFM) in children with conditions other than cerebral palsy (CP).

METHOD

A systematic review was conducted using five electronic databases to identify studies that used the GMFM in children with conditions other than CP. Methodological quality and measurement properties were evaluated using established standards for assessing outcome measures.

RESULTS

We identified 210 studies across various paediatric conditions. Measurement property studies examined eight conditions: acquired brain injury, spinal muscular atrophy, Fukuyama congenital muscular dystrophy, Down syndrome, osteogenesis imperfecta, acute lymphoblastic leukaemia (ALL), leukodystrophy, and Pompe disease. Evidence quality was generally low to very low owing to small sample sizes and methodological limitations. Reliability showed sufficient ratings across most conditions. Content validity was examined only for ALL and demonstrated sufficient ratings. Responsiveness and construct validity showed variable results across conditions. Clinical application analysis revealed inadequate methodological reporting and widespread use without appropriate validation.

INTERPRETATION

GMFM validation for conditions other than CP remains insufficient despite widespread use. Content validity verification and enhanced methodological rigor are critically needed. Clinicians should interpret results cautiously until robust validation is established.

摘要

目的

探讨粗大运动功能测量量表(GMFM)在脑瘫(CP)以外疾病儿童中的应用情况,并评估其测量特性。

方法

使用五个电子数据库进行系统评价,以识别在CP以外疾病儿童中使用GMFM的研究。采用评估结局指标的既定标准对方法学质量和测量特性进行评估。

结果

我们在各种儿科疾病中识别出210项研究。测量特性研究考察了八种疾病:获得性脑损伤、脊髓性肌萎缩症、福山型先天性肌营养不良、唐氏综合征、成骨不全症、急性淋巴细胞白血病(ALL)、脑白质营养不良和庞贝病。由于样本量小和方法学局限性,证据质量普遍较低至极低。在大多数疾病中,可靠性显示出足够的评分。仅对ALL进行了内容效度检查,结果显示评分足够。反应度和结构效度在不同疾病中的结果各异。临床应用分析显示,方法学报告不足,且在未进行适当验证的情况下广泛使用。

解读

尽管GMFM被广泛使用,但在CP以外疾病中的验证仍然不足。迫切需要进行内容效度验证并提高方法学严谨性。在建立可靠的验证之前,临床医生应谨慎解释结果。